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Abstract
Background: Pseudomonas aeruginosa Sequence Type 235 is a clone that possesses an extraordinary ability to
acquire mobile genetic elements and has been associated with the spread of resistance genes, including genes
that encode for carbapenemases. Here, we aim to characterize the genetic platforms involved in resistance
dissemination in blaKPC-2-positive P. aeruginosa ST235 in Colombia.
Results: In a prospective surveillance study of infections in adult patients attended in five ICUs in five distant cities in
Colombia, 58 isolates of P. aeruginosa were recovered, of which, 27 (46.6%) were resistant to carbapenems. The
molecular analysis showed that 6 (22.2%) and 4 (14.8%) isolates harboured the blaVIM and blaKPC-2 genes, respectively.
The four blaKPC-2-positive isolates showed a similar PFGE pulsotype and belonged to ST235. Complete genome
sequencing of a representative ST235 isolate shows a unique chromosomal contig of 7097.241 bp with eight different
resistance genes identified and five transposons: a Tn6162-like with ant(2″)-Ia, two Tn402-like with ant(3″)-Ia and blaOXA-2
and two Tn4401b with blaKPC-2. All transposons were inserted into the genomic islands. Interestingly, the two Tn4401b
copies harbouring blaKPC-2 were adjacently inserted into a new genomic island (PAGI-17) with traces of a replicative
transposition process. This double insertion was probably driven by several structural changes within the chromosomal
region containing PAGI-17 in the ST235 background.
Conclusion: This is the first report of a double Tn4401b chromosomal insertion in P. aeruginosa, just within a new
genomic island (PAGI-17). This finding indicates once again the great genomic plasticity of this microorganism.
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Background
Pseudomonas aeruginosa is an opportunistic pathogen
that causes numerous infections in hospitalized pa-
tients, especially in the intensive care unit (ICU),
some of which are difficult to treat because of their
multidrug-resistant (MDR) phenotype. In P. aerugi-
nosa carbapenem resistance has been associated
mainly with two different mechanisms: first by pre-
venting the access of the antibiotic to its active site
by means of chromosomal mutations that upregulate
of multidrug efflux systems or alterations in the outer
membrane permeability and second by the acquisition
and production of carbapenemases [1]. In the last
case, the most frequent carbapenemases found in P.
aeruginosa are GES, IMP, VIM, SPM and more re-
cently KPC and NDM [1–6].
The KPC enzyme is the most frequent class A car-
bapenemase and has been reported in countries from
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five continents. KPC has been found mainly in the
epidemic Klebsiella pneumoniae ST258 clone and in
some Enterobacteriaceae [7]; however, it has also been
identified in P. aeruginosa, first in Colombia [2], then
in Trinidad and Tobago [8], the United States of
America [3], Puerto Rico [9], China [10] and Brazil
[11]. The blaKPC gene (that encodes the KPC enzyme)
is mobilized on Tn4401, an active transposon belong-
ing to the Tn3 family, with a size of 10 kb, that is
delimited by two 39-bp inverted repeat sequences,
and its replicative transposition involves a 5-bp target
site duplication, without target site specificity [12].
Currently, eight different isoforms of Tn4401 have
been reported (a-h), which differ by size-variable dele-
tions upstream at the blaKPC gene, truncated tnpA or
lacking tnpR [13, 14]. In P. aeruginosa, the blaKPC
gene is rare (with variant 2 being the most frequent)
and is mainly mobilized on both complete or trun-
cated Tn4401b transposons, which have been reported
in two different plasmid backbones (8 kb and 31.5 kb)
belonging to the IncU and IncP-6 incompatibility
groups, respectively [15, 16]. This blaKPC-2 variant has
been identified in P. aeruginosa isolates belonging to
sequence type (ST) 308, 1006, 1060 and 235 [15–17].
Pseudomonas aeruginosa ST235 is an infectious and
virulent clone that possesses an extraordinary ability
to acquire mobile genetic elements (MGE) and has
been associated with the spread of multiple resistance
genes, including genes that encode for carbapene-
mases [18–20]. Currently, this clone has been identi-
fied across the world, showing great disseminative
success [18, 19, 21, 22]. The genomic plasticity of P.
aeruginosa can be seen in ST235 strains, where the
content of the resistance genes varies greatly due to
the capture, permanence and rearrangement of resist-
ance regions [18, 23, 24]. In Colombia, the ST235
clone has become prevalent since 2005 and has suf-
fered an evolution in clinically important resistance
genes by lateral gene transfer (LGT), e.g. some strains
have acquired an atypical active class 1 integron with
an unusual 3′ consensus sequence (tni module),
which can provide a putative self-transposition ability
[25], the acquisition of IS26 and the blaKPC-2 gene,
which are most frequent in Enterobacteriaceae but
rare in P. aeruginosa [2, 25]. In this study, after active
clinical surveillance in the ICU at five distant cities,
we found a broad population distribution of P. aeru-
ginosa in Colombia; nonetheless, the ST235 clone was
the only one harbouring blaKPC-2, and interestingly,
those ST235 isolates harboured two copies of this
gene that were located in two Tn4401b transposons
in a new genomic island (GI) at the chromosome. As
far as we know, this is the first report of a double
chromosomal blaKPC-2 insertion in P. aeruginosa.
Methods
Strain collection, susceptibility profile and PCR detection
of resistance genes
This prospective study was carried out based on the ac-
tive surveillance of P. aeruginosa infections in adult pa-
tients who were attended in five ICUs in five distant
cities in Colombia between October 2014 and March
2016. A total of 58 P. aeruginosa isolates were recov-
ered. The susceptibility profiles of the isolates to
meropenem, imipenem, ertapenem and doripenem, cef-
tazidime, gentamicin, amikacin, ciprofloxacin, trimetho-
prim/sulfamethoxazole, and Piperacillin/Tazobactam
were determined by the automated systems VITEK® 2
or Microscan®. Additionally, the minimum inhibitory
concentration (MIC) was established by the broth dilu-
tion method. The susceptibility profiles were estab-
lished using the breakpoints defined by the Clinical and
Laboratory Standards Institute according to the 2017
update [26]. The ATCC 9721 P. aeruginosa strain was
used as control. In addition, the following resistance
genes were assessed in all the isolates: blaTEM, blaSHV,
blaCTX-M, blaFOX, blaACT, blaMIR blaACC, blaDHA,
blaCMY, blaMOX, blaIMP, blaOXA-48, blaVIM, blaGES,
blaKPC, blaNDM, blaOXA-23, blaOXA-24, blaOXA-43,
blaOXA-51, blaOXA-58, aac(6′)-lb, aac(6′)-lb-cr, qnrA, B y
S, mcbg, sul1, sul2 and sul3. The blaKPC-2 variant was
determined by digestion with RsaI enzyme and con-
firmed by sequencing. Finally, the intl1, intl2 and intl3
genes were assessed.
Phylogenetic relationship among Pseudomonas
aeruginosa isolates
The genetic relatedness between the isolates was deter-
mined by genome macro-restriction using the SpeI en-
zyme (Promega) and PFGE separation according to the
protocol reported by Herschleb et al [27]. The dendro-
gram was obtained using the GelCompar II program
(Applied Maths NV) with a tolerance position of 1.5%
and a Dice coefficient of 1.0%. Two pulsotypes were
considered different when they had < 80% similarity. The
sequence type (ST) to some representative isolates of the
most frequent pulsotypes was determined using the
protocol reported by Curran et al [28].
Whole genome sequencing of a ST235 blaKPC-2-positive
Pseudomonas aeruginosa isolate
The complete genome sequence of the ST235 blaKPC-2--
positive 24pae112 isolate was obtained using the PacBio
RS II platform (Pacific Biosciences, USA) and assembled
through the previously reported procedure [29]. In brief,
the total DNA was extracted, and a BluePippin (Sage
Science) 20-kb size-selected library was prepared and
then sequenced using one SMRT cell on the PacBio RS
II platform. The sequencing process of the 24Pae112
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isolate yielded 136,958 reads and a total of 1,221,367,395
bases (coverage of 172X). Sequencing reads were de
novo assembled using the HGAP 3 protocol with default
parameters. The assembly was visually inspected and
manually verified using BWA-MEM (Burrows-Wheeler
Aligner with maximal exact matches) [30] and Tablet
v1.15.09.01 [31]. Misassembled terminal repeat overlap
sequences were identified with Gepard (Genome Pair
Rapid Dotter) [32] and trimmed manually. The whole
genome was annotated using Prokka v1.11 [33], and the
interesting regions were manually confirmed using
BLASTn and BLASTp and edited in Artemis [34].
Phylogenetic analysis and comparative genomics of
ST235 isolates
To perform the phylogenetic analysis and comparative
genomics, the 43 publicly available P. aeruginosa ST235
genomes at the time were included (41 drafts and 2
complete genomes available at the NCBI genomes re-
pository in January 2017), plus the genomes of the
24pae112 and 9Ps50 isolates (Additional file 1: Table
S1). This 9Ps50 isolate was previously identified in 2006
by our group, causing an infection in institution C
(included in this study), and did not harbour blaKPC-2
[25]. To build the phylogenetic tree based on the
core-genome SNPs, partially assembled genomes were
annotated using Prokka v1.11 [33], and an alignment of
the concatenated core genes (genes present in all ge-
nomes with ≥90% of nucleotide identity) was created
with Roary [35] using PRANK [36]. Poorly aligned posi-
tions and divergent regions were eliminated using
Gblocks [37]. The phylogenetic tree was created using
RAxML version 8.2.9 [38] running 1000 bootstrap repli-
cates under the generalized time reversible model
(GTRCAT). Finally, the consensus tree was plotted using
Dendroscope [39]. Branch lengths are expressed in
changes/nucleotide position (scale bar). In addition, an
accessory-genome-based phylogenetic tree was built
(presence/absence of genes) to assess the genetic diver-
sity of the foreign DNA into the ST235 clone using the
programs mentioned above.
A genomic comparative analysis was performed to de-
termine the genetic variability in all P. aeruginosa ST235
strains using BLASTn [40] and visualized with BRIG.
Genomic and pathogenicity islands (GI and PI, respect-
ively), prophages, insertion sequence (IS) elements and
transposons were identified using IslandViewer [41],
PHASTER [42] and ISfinder [43]. The genetic platforms
identified were visualized and illustrated by Artemis
[34], ACT [44] and EasyFig [45].
Resistome identification
To determine the resistance gene content variability in the
P. aeruginosa ST235 clone, the antibiotic resistance genes
were identified in the genome of all the sequenced ST235
isolates using ARIBA (https://github.com/sanger-patho-
gens/ariba/wiki), with the ResFinder [46], CARD (The
Comprehensive Antibiotic Resistance Database) [47] and
ARG-ANNOT (Antibiotic Resistance Gene-ANNOTat
ion) [48] databases. The results were visualized through
Phandango software.
Results
In the surveillance study, we identified 58 P. aeruginosa
that caused ICU infections among adult patients. With
respect to the resistance behaviour, among all 58 iso-
lates, 27 (46.6%) were resistant to at least one carba-
penem antibiotic (imipenem, meropenem, ertapenem or
doripenem). Of these 27 carbapenem-resistant P. aerugi-
nosa, six (22.2%) and four (14.8%) isolates contained the
blaVIM and blaKPC-2 genes, respectively. Multilocus se-
quence typing shows that the six blaVIM-positive isolates
belonged to four different ST’s: ST111 (two isolates) pre-
viously reported in other Colombian cities [17]; ST244
(one isolate) reported in Europe [49, 50], Asia [21] and
Africa [51]; ST1978 (two isolates), which was not re-
ported previously; and ST235 (one isolate). Interestingly,
all blaKPC-2-positive isolates only belonged to ST235.
Analysis of the meropenem MIC showed a heteroge-
neous behaviour among the carbapenem-resistant iso-
lates. Nine isolates reached an MIC value of 1024 μg/ml;
among them were all the blaKPC-2-positive ST235
isolates and two blaVIM-positive ST111 isolates. Curi-
ously, three isolates had an MIC of 1024 μg/ml but did
not contain any of the assessed carbapenemases genes
(Fig. 1).
Fig. 1 Behaviour of the minimum inhibitory concentration (MIC) to
meropenem of the 27 carbapenem-resistant isolates. Yellow and red
points indicate the VIM-producing and KPC-producing isolates,
respectively. ST: Sequence type
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The PFGE analysis revealed 34 pulsotypes in the 58 P.
aeruginosa isolates, showing a polyclonal behaviour. The
six VIM-producing isolates were found in four unrelated
PFGE pulsotypes, each of them with a different ST, sug-
gesting that diverse clones have acquired this carbapene-
mase (Additional file 2: Figure S1). In contrast, in the
four KPC-2-producing isolates (24Pae65, 24Pae112,
24Pae153 and 24Pae250), two very similar PFGE pulso-
types (a unique band of difference, > 95% of similarity)
were found (Additional file 2: Figure S1).
Genomic comparative analysis of the ST235 isolates
In order to go deeper into the genetic platforms mobiliz-
ing the blaKPC-2 and other resistance genes, the complete
genome sequence of the 24Pae112 isolate was established.
After PacBio sequencing and assembly process, the
24Pae112 genome had a size of 7097,245 bp, in a unique
contig (suggesting that this isolate does not contains plas-
mids), with a 66.0% G +C content, comprising 6634 pre-
dicted genes (coding density of 88.2%), which include 328
(4.9%) membrane transport proteins, 224 (3.4%) cell wall
synthesis proteins, 202 (3.0%) virulence factors (pathogen-
icity and defence), 97 (1.5%) proteins of mobile genetic el-
ements (prophages, insertion sequences and transposons),
63 (0.9%) tRNAs and 12 (0.2%) rRNAs. The antimicrobial
resistome to the 24Pae112 chromosome evaluated using
ARIBA included resistance genes to aminoglycosides
(ant(2″)-Ia, ant(3″)-Ia and aph(3′)-IIb), beta-lactams
(blaOXA-2 and blaKPC-2), sulphonamides (sul1), chloram-
phenicol (catB7) and fosfomycin (fosA). In addition, 8
prophages, 7 genomic islands (GI) and the different
transposons within them were identified in the genome
(Table 1). Recently, 40 and three ST235 genomes
(complete or draft) were reported at the public NCBI gen-
ome database from the different countries, and we per-
formed a phylogenetic analysis based on the core genome
SNPs to determine the relationship between them and the
Colombian ST235 isolates (Fig. 2). This analysis reveals
that ST235 can be divided in two different genetic clades
(Clade 1 and 2), showing the circulation of two genetic
“sublineages” within the ST235 clone. No phylogenetic
correlation with the origin country or identification date
could be demonstrated because several isolates do not
cluster according to their geographic origin or the date
when they were identified, e.g. of the nine isolates
identified in the USA, seven and two were grouped in
clade 2 and 1, respectively; the six Colombian isolates
were grouped in each of the clades. Meanwhile, the
24Pae112 and 9Ps50 isolates were grouped in different
clades. These results suggest that two genetic “subli-
neages” are circulating within the ST235 clone.
Interestingly, the accessory-genome-based tree of the
ST235 clone contained more branches than the
core-genome-based tree, showing a relatively wide gen-
etic variability in the accessory genome of the ST235
isolates. The gene content on the accessory genome of
the 24Pae112 isolate was closely related to the
AZPAE14726 isolate that was identified in the USA in
2012, and very distant to the other Colombian ST235
isolates suggesting that the 24Pae112 isolate acquired a
very different accessory DNA, perhaps by differential
LGT events.
Table 1 Genomic islands and prophages present in the Pseudomonas aeruginosa 24Pae112 genome
Genomic island (GI) or prophage (PP) Start End Size (bp) GenBank accession numbera % of 24Pae112 coverage % of Identity
H70 1st copy (PP) 262,871 300,420 37,549 NC_027384 80 91
H70 2nd copy (PP) 5,678,768 5,716,362 37,594 NC_027384 82 91
PM105 1st copy (PP) 2,541,628 2,580,611 38,983 NC_028667 79 98
PM105 2nd copy (PP) 2,940,222 2,979,923 39,701 NC_028667 82 97
D3 (PP) 3,879,471 3,936,450 56,979 NC_002484 44 95
F10 (PP)b 5,053,812 5,092,700 38,888 NC_007805 13 94
phiCTX (PP) 705,252 724,278 19,026 NC_003278 2 78
Pf1 (PP) 5,347,267 5,358,785 11,518 NC_001331 80 98
PAGI-1 (GI) 3,366,957 3,406,228 39,271 AF241171 76 99
PAGI-2 (GI) 2,310,022 2,363,289 53,267 AF440523 33 99
PAGI-4 (GI) 4,795,506 4,895,009 99,593 AY258138 61 99
PAGI-5 (GI)b 5,752,816 5,853,757 100,941 EF611301 70 99
PAGI-6 (GI) 6,593,897 6,630,920 37,023 EF611302 66 97
GI1 (GI)b 2,403,928 2,472,004 68,076 EU595750 91 99
PAGI-17 (GI)b 2,724,254 2,841,225 116,971 NC_018080 90 99
aGenBank accession number of sequence used as reference
bHarbouring transposons with resistance genes
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Pseudomonas aeruginosa ST235 resistome
The P. aeruginosa ST235 clone is recognized for its abil-
ity to acquire and spread resistance genes worldwide.
We determined the resistance genes repertoire in the 45
ST235 genomes included in the study. Multiple resist-
ance genes to different families of antibiotics were found
(Fig. 3). Of note, five different genes related to carba-
penem resistance were found distributed in 8 countries:
blaGES, blaKPC-2, blaVIM-11, blaIMP-1, and blaVIM-13 in 10
(22.2%), 4 (8.9%), 4 (8.9%), 3 (6.7%) and 1 (2.2%) isolates,
respectively. Nonetheless, the gene blaKPC-2 (the unique
variant detected in this clone) was exclusively found in
the Colombian ST235 isolates, showing that the acquisi-
tion of this gene by the ST235 clone may be a particular
phenomenon in our country. In addition, 22 gene vari-
ants related to aminoglycoside resistance were identified.
The qnr, mcbg and aac(6′)-Ib-cr genes related to
plasmid-mediated quinolone resistance were not found.
Diverse genetic platforms transport resistance genes in
24Pae112 isolate
To gain a better understanding of the complex process
of the acquisition of resistance genes by the 24Pae112
isolate, the genetic platforms transporting these genes
were identified, and the genome localization was com-
pared with the remaining ST235 genomes and visualized
with BRIG (Figs. 4 and 5). Five transposons were identi-
fied to harbour resistance genes: the Tn6162-like trans-
poson with a size of 34,220 bp, which was located in P.
aeruginosa genomic island 1 (GI-1). This transposon
harbours a classical class 1 integron with the gene cas-
sette array aadB-gcuD (Fig. 5a). Sample 24Pae112 also
harbours two distant copies of the Tn402-like trans-
poson, with the first one in the prophage F10 and the
second one in the PAGI-5. Curiously, both transposons
contained a class 1 integron structure, but with different
variable regions, harbouring only one gene cassette,
Fig. 2 Maximum likehood phylogenetic tree based on core (a) and accessory (b) genome of the 45 ST235 isolates. The isolates are named as
follow: strain name, acronym of the origin country in bold (see Additional file 1: Table S1) and date of identification. The strains that start as
AZPAE1 were simplified in the figure as A1. The branches into the tree were established when the sum of all internal nodes were≤ 2, every
branch is show in different colours. The bar scale (1.0 and 0.001) indicate the SNP number
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aadA1 and blaOXA-2, respectively (Fig. 5b and c). In
addition, two blaKPC-2-harbouring Tn4401b transposons
were also identified (see below). It was not possible to de-
termine the genetic platforms mobilizing the aph(3′)-IIb,
catB7 and fosA genes.
Two blaKPC-2-harbouring Tn4401b are inserted into the
24Pae112 chromosome
Surprisingly, the genome sequence analysis of 24Pae112
reveals the presence of two complete and intact copies
of blaKPC-2-harbouring Tn4401 (isoform b) transposons
inserted into the chromosome within a new genomic is-
land (Figs. 5d and 6). Comparative genomic analysis
allowed us to establish that this same genomic island
had already been described by Rau et al. in the P. aerugi-
nosa DK2 clone and named generically as GI4 [52]; how-
ever, the sequence and structure of this island is
different with respect to the 16 PAGI currently reported
(including PAGI-4, data not shown) [53–57]. Conse-
quently, here, we renamed this genomic island as
Pseudomonas aeruginosa genomic island 17 (PAGI-17),
according to the widely accepted nomenclature system
used for genomic islands in this microorganism [53–57].
This double Tn4401b chromosomal insertion was
experimentally confirmed by PCR using specific primers
(data not shown). The two Tn4401b copies were
Fig. 3 Resistome of Pseudomonas aeruginosa ST235 clone. Resistance genes identified in the strains belonging to ST235. The blue and red
squares represent the presence of the resistance genes and the isolates harbouring the blaKPC gene, respectively. The isolates are named as
follow: strain name, acronym of the origin country in bold (see Additional file 1: Table S1) and date of identification. The orange circle indicates
the position of the 24Pae112 isolate
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identical, with a size of 10,006 bp, in an inverted orienta-
tion, for a separate DNA fragment of 5877 bp, which
harbours the parB, yhbS, chrA, padR and arsC genes.
The first Tn4401b copy was inserted within the acr3
gene, which encodes the Acr3 protein related to arsenic
resistance [58], with a 5-bp target site duplication
(CTGCT). The second Tn4401b copy was inserted
within the acrB gene, which encodes the transporter
protein AcrB, related to acriflavine, antibiotics, disinfec-
tants, dyes, and detergent resistance; AcrB gene is lo-
cated upstream of the acrA gene which encodes the
RND multidrug efflux membrane permease protein
AcrA. The second insertion generated a 5-bp distinct
target site duplication (GTCCA) (Fig. 7). This confirms
the lack of target site specificity of this transposon, as
has previously been reported [12].
Although the information about PAGI-17 is very lim-
ited, to unravel the genetic mechanisms that possibly
allow the Tn4401b chromosomal insertion, a more de-
tailed analysis of this genomic island was carried out.
Comparing the chromosome sequence of the reference
strain P. aeruginosa PAO1 (devoid of PAGI-17) with the
24Pae112 genome, we determined that in 24Pae112, the
PAGI-17 was inserted at the tRNAGly gene, in the posi-
tions 2,724,254 to 2,841,225 (to the 24Pae112 genome).
The PAGI-17 insertion produced the duplication of a
16-bp sequence (CTCGTTTCCCGCTCCA) located at
the 3′-end of the tRNAGly gene (Fig. 7). The duplication
did not alter the sequence of this gene. The total size of
PAGI-17 in 24Pae112 was 116,971 bp, with a G + C con-
tent of 64.1% and 113 open reading frames. Comparing
PAGI-17 from 24Pae112 with PAGI-17 from P. aerugi-
nosa DK2, we identified an additional 16-bp identical
sequence (CTCGTTTCCCGCTCCA, similar to that
generated by the PAGI-17 insertion in 24Pae112) located
downstream of the second duplicated sequence. This
new duplication delimits a fragment of a 2264-bp, which
is unique in the 24Pae112 PAGI-17 and harbours the
fimA gene that encodes the type 1 fimbria component
protein, an important virulence factor that mediates
mannose-sensitive adherence to the eukaryotic cell.
Analysis of the chromosomal environment surround-
ing the Tn4401b insertion sites revealed a 24,134-bp
specific DNA fragment, which is rarely found in P.
Fig. 4 Genomic comparison of Pseudomonas aeruginosa ST235 isolates. Matched alignment between 24Pae112 genome and the 40 and four
remain ST235 genomes visualized using BRIG, the order of the strains in the rings can be seen in Additional file 1: Table S1. The colours of every
ring indicate the continent of the origin and the colour intensity represents the identity percentage. The outer ring shows the location of
resistance genes and their genetic platforms of mobilization (when was identified), genomic islands and prophages in 24Pae112
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aeruginosa since it was only found in PAGI-17 in five
unrelated P. aeruginosa strains: DK2-CF333(ST386),
SCV20265 (ST299), PAER4 (ST260), 8380(ST2619) and
BAMCPAO7 (ST313). None of the ST235 isolates con-
tained this region (Fig. 7). While the complete or trun-
cated PAGI-17 is present in several P. aeruginosa
strains, only six strains (including the 24Pae112) possess
this 24,134-bp-size DNA fragment. Interestingly, a gen-
omic comparative analysis carried out by Rau et al. on
45 isolates belonging to the DK2 lineage and recovered
from patients suffering from cystic fibrosis over the
course of 35 years (from 1973 to 2008) found that this
24,134-bp DNA fragment was acquired early in the DK2
lineage. Specifically, the DK2-CF114 isolate (the first
DK2-lineage isolate recovered at 1973) did not contain
exactly this fragment, whereas the remaining 44 isolates
incorporated it into their chromosomes [52]. This result
suggests that this DNA portion was possibly acquired by
LGT in P. aeruginosa a long time ago in a few genetic
lineages, including the ST235 clone. The acquisition of
this DNA may favour the incorporation and permanence
of the two Tn4401b-blaKPC-2 transposons.
Discussion
The problem of resistance to carbapenems has become
highly relevant for the health care authorities, as this
Fig. 5 Organization of the different genetic platform harbouring resistance genes within the 24Pae112 isolate. a Tn6162-like transposon inserted
into the genomic island 1. b First copy of the Tn402-like transposon inserted into the prophage F10. c Second copy of the Tn402-like transposon
within the PAGI-5. d Two copies of the Tn4401 transposon into the new genomic island PAGI-17. IR: Inverted repeats
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class of antibiotics has frequently been used as the
last-line-of-defence agents to treat serious bacterial in-
fections. Additionally, carbapenem resistance is a much
bigger problem in non-fermentering bacteria, such as P.
aeruginosa and Acinetobacter baumanni, because these
bacteria possess frequent resistance (intrinsic or ac-
quired) to other families of antibiotics, and the lack of
available treatment options against some MDR strains is
worrying. In our study, we found that almost half
(46.6%) of the P. aeruginosa isolates were already resist-
ant to carbapenems, which is alarming given that in
Colombia the number of MDR P. aeruginosa infections
in hospitalized patients has risen [59]. High percentages
of carbapenem resistance have been reported in other
countries, such as Brazil (43.9%), Spain (88.0%) and Iran
(96.0%) [60–62]. Additionally, among all the carbapenem
resistant isolates, almost 40% are produced by carbape-
nemase production (VIM and KPC) in different clones
(ST111, ST244, ST1978 and ST235). We identified four
blaKPC-2-positive and multidrug resistant isolates belong-
ing to ST235 (only susceptible to colistin), but these do
not contain the blaKPC-2–harbouring plasmids that were
previously reported [15, 16]. For these reasons, we per-
formed complete genome sequencing of the blaKP-
C-2-harbouring P. aeruginosa isolates to establish the
different genetic platforms moving the resistance genes.
Fig. 6 Comparison of the different genetics platform mobilizing blaKPC-2 gene in Pseudomonas aeruginosa. The pPA-2 (KC609322.1) and pCOL-1
(KC609323.1) plasmids were identified in Colombia; the p10265-KPC plasmid (KU578314.1) was identified in China
Fig. 7 Insertion sites analysis of the two blaKPC-2-harbouring Tn4401b transposons and PAGI-17. The PAGI-17 was inserted at tRNA
Gly gene as it is
showed in the PAGI-17-negative PAO1 reference strain (NC_002516.2). The two couples of Tn4401b direct repeats and the three direct repeats of
the PAGI-17 are showed. The GenBank accession number for DK2, LESlike1, LESlike4, LESlike5 and LESlike7 genomes are NC_018080.1,
NZ_CP006984.1, NZ_CP006985.1, NZ_CP006980.1 and NZ_CP006981.1; respectively
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This analysis led us to find a new feature in the dynamic
blaKPC-2 gene mobilization through Tn4401 in this
bacterium.
The blaKPC-2 gene in P. aeruginosa was first reported
in Colombia in 2007 [2] but has already been found in
several countries, including the United States of America
and China [3, 10, 11]. Previous studies in P. aeruginosa
revealed that the blaKPC-2 gene is mobilized into only
one copy of Tn4401 (complete or truncated forms)
within the two plasmid backbones. However, comparison
of the genetic structures surrounding Tn4401b in the
24Pae112 isolate indicate to us that its incorporation
was not produced by the chromosome integration of any
two previously identified Inc-P or Inc-U plasmids in
Colombia (Fig. 6) [15]. Conversely, the Tn4401b acquisi-
tion occurred by transposition at two different, but
nearby sites. As far as we know, this is the first report of
a double chromosomal blaKPC-2–harbouring Tn4401 in-
sertion in P. aeruginosa. Even though this duplication is
a rare genetic event, it was previously reported within a
70.6-kb plasmid from a Klebsiella pneumoniae S9 strain
identified in New York [63]. Although the Tn4401 dupli-
cation could provide higher production of the KPC en-
zyme, it is necessary to determine whether it provides
any advantage in the carbapenem hydrolysis and conse-
quently an increase in the carbapenem MICs.
The origin of Tn4401b in the 24Pae112 isolate is un-
known, although it may be related to the process of inter-
cellular mobility (the MGE may be excised from one
location and to undergo replicative transposition before to
be reintegrated elsewhere in the genome) [64] from a plas-
mid. The 24Pae112 isolate probably acquired a blaKPC-2–
harbouring plasmid from a Klebsiella pneumoniae isolate
that favoured Tn4401b transposition to the chromosome,
given that the KPC-producing Klebsiella pneumoniae
clone is already endemic in Colombia. This Tn4401b
mobilization from the plasmid to the chromosome has
already been reported in Klebsiella pneumoniae [63].
Our comparative genomic analysis shows a relatively
high variability in the accessory genome of ST235 isolates,
suggesting great genome plasticity in this clone. This gen-
omic flexibility could contribute to the fact that the ST235
clone can survive in the most hostile environments. The
variability in the accessory genome is produced for the dif-
ferential acquisition of diverse MGE, such as prophages,
genomic islands and transposons (in some cases moving
resistance genes), and for changes within them produced
by genetic recombination events, duplications and dele-
tions mediated by transposases and recombinases [64]. In
the case of the 24Pae112 isolate, this was probably neces-
sary for several genetic events to occur before the double
Tn4401 insertion was done. First, the acquisition of
PAGI-17 by different genetics lineages, including an
ST235 common ancestor because it is in almost all the
ST235 isolates. Second, the insertion of a 24-kb fragment
within the 5′ region of PAGI-17, this is not a genetic
phenomenon exclusively associated with the ST235 clone,
given that it was only found in 24Pae112. However, it is
also a rare event in P. aeruginosa because it was only
found in five isolates belonging to different genetic line-
ages (ST386, ST299, ST260, ST2619, and ST313). Third,
the acquisition and maintenance of a MGE (plasmid) har-
bouring a Tn4401b transposon, and fourth, the transpos-
ition of the Tn4401 from MGE to the chromosome within
a site that did not affect the essential genes for the bac-
teria, such as PAGI-17.
From the clinical point of view, the great genomic
plasticity of P. aeruginosa and its extraordinary ability to
incorporate several copies of resistance genes generates
an elevated production of B-lactam antibiotic-degrading
enzymes; this limits the carbapenem use and pose the
urgent need to find different treatment strategies, such
as the use of combined antibiotics and the development
of new therapeutic technologies. Accordingly, knowing
in detail the mechanisms of bacterial resistance is an im-
portant factor to contain and prevent this great problem.
For other hand, the 24Pae112 isolate was recovered from
a remitted patient, who had a healthcare-associated
bloodstream infection, suggesting that this P. aeruginosa
clone could be already circulating in other regions of the
country. Understanding the dynamics of the transfer of
elements that confer resistance is one of the important
factors to design the best practices to prevent the spread
of multidrug resistant bacteria and healthcare-associated
infections.
Conclusion
Our findings together with those previously reported in
the ST235 clone show the extraordinary genomic plasti-
city of Pseudomonas aeruginosa, quality that allows it to
acquire, keep and modify foreign DNA into its genome.
This DNA acquisition contributes to more genetic arma-
ment to face new hostile environmental conditions, such
as high concentrations of antibiotics. Our findings also
indicate the essential role that genomic islands play in
the constant and successful evolution of P. aeruginosa.
This has been demonstrated here with the PAGI-17, but
it has also been demonstrated for PAGI-1 and -2 [22]
because they serve as both catchers and natural “ware-
houses” of foreign DNA storage, where this bacterium
can keep virulence and resistance genes with few sec-
ondary effects on its genome stability.
Additional files
Additional file 1: Table S1. Characteristics of the P. aeruginosa ST235
genomes included in the phylogenetic tree and the genomic
comparative analysis. (XLSX 16 kb)
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Additional file 2: Figure S1. Genetic relationship by PFGE of the
carbapenem-resistant P. aeruginosa isolates identified in the study. The black
line corresponds to a genetic relationship of 80% of similarity. Numbers in
the colour boxes indicate to the main PFGE pulsotype found. ST: Sequence
type. The abbreviations in the susceptibility profile: TZP: piperacillin/tazobac-
tam, CAZ: ceftazidime, MEM: meropenem, DOR: doripenem, IMP: imipenem,
STX: trimethoprim/sulfamethoxazole, CIP: ciprofloxacin, AK: amikacin, GEN:
gentamicin y COL: colistin. The isolate marked with asterisk (*) was selected
to whole genome sequencing. (TIF 445 kb)
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